Canada markets open in 5 hours 3 minutes

Columbia Care Inc. (CCHWF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.4500+0.0150 (+1.05%)
At close: 03:58PM EDT
Sign in to post a message.
  • K
    Kevin
    Merger is a good deal for CC shareholders based on the current exchange rate for Cresco shares
  • T
    Tom
    $CRLBF conversation
    Read a piece on what happens after buying assets after a draw down of 60-90% in a particular industry, sector or country. It's by Meb Faber CIO at Cambria wrote it. Basically, this sector is a lock for 3yrs = 2x+ And remember, that doesn't account for any positive change in federal law that would allow NYSE/NASDAQ listings, see e.g. $IIPR 's 5yr performance of >5.5x. I've put money where the mouth is too buying $CCHWF as I think the Cresco deal goes through. Good times ahead, IMO by EOY.
  • T
    Tom
    $CURLF conversation
    $CURLF, $TCNNF, $GTBIF, $VRNOF, $CRLBF, $MSOS, $CCHWF

    If you missed the rally today, watch for the end of day/closing. You can pickup shares cheap as shorts try to drive down the price gains as much as they possibly can on low volume. I will be waiting!
  • M
    Mark
    this is what i understand to be the agreement, "Cresco will acquire all of the issued and outstanding common shares and proportionate voting shares of the Company in accordance with the terms of an arrangement agreement dated March 23, 2022 (the "Arrangement Agreement") between Columbia Care and Cresco," meaning the price will be based on the price of both companies on March 23, 2022.

    compared to today's prices that's a good deal. please correct me if i'm wrong. i'd like be to real on this.
  • M
    Mark
    POLITICS

    American Medical Association Approves Marijuana Expungements Resolution And Addresses ‘Over-Medicalization’ Of Cannabis

    #cchwf #ffntf #crlbf #curlf #gtbif #tcnnf
  • R
    Richard
    This downtrend here and on all other MSO's makes zero cents at this point. Who is still selling that didn't exit already? Why would today or Tomorrow suddenly be the day people tap out after several months of downtrend? If it goes down more Tomorrow or the next day, why didn't those sellers get out today instead?
    Its such b.s. manipulation at this point. All the fear sellers already gone. Why do the shorts continue to risk it in territory where everyone else but the shorts are now buyers? Lol why is everyone waiting on legalization to get in when the industry is making big money now and growing???
    Everything is psychological now, fundamentals do not exist in this market. Sad.
  • j
    jj
    $VRNOF conversation
    $MSOS, $AYRWF, $CCHWF, $CRLBF, $CURLF, $GTBIF, $JUSHF, $GRWG, $TCNNF, $TRSSF, $VRNOF
    The Etf MSOS had no changes to the top ten positions this past week.
    The AUM dropped to $583.9 millions.
    TCNNF is #1 at 17.41%,, CURLF 14.74%, VRNOF 13.76%, GTBIF 13.38%,
    CURLF 7.30%, TRSSF 5.05%, CCHWF 3.92%, AYRWF 3.69% and JUSHF 2.66%. The top 10 make up 82.01% of the AUM.
  • M
    Mark
    did you vote?
  • j
    jj
    $VRNOF conversation
    $MSOS, $AYRWF, $CCHWF, $CRLBF, $CURLF, $GTBIF, $JUSHF, $GRWG, $TCNNF, $TRSSF, $VRNOF. Industry commentary from NCV…
    Friends,
    Two weeks ago, we suggested that the Global Cannabis Stock Index, then down 43% in 2022, was likely to bottom before year-end. It has fallen further (by 15.4% subsequently) and is now about 52% lower this year. The bullish factors we cited then are still intact, and we are more interested than two weeks ago at these lower prices. Despite that, we are clearly in a bear market for stocks generally, and our optimism doesn't help in choosing the best time to enter or to expand positions in the cannabis sector. The future looks very bright in contrast to the price action lately, and we want to discuss how investors should be prepared for changes ahead.

    We are expecting big market growth in several states. Illinois is currently increasing its dispensary count by more than 100%. Two weeks ago, we mentioned Eastern states generally. Today, we want to refine that observation and mention New York and New Jersey, both transitioning to adult-use, at the top of the list. Virginia can also be included, and there are some other states like Maryland, Ohio and Pennsylvania that may move to legalize adult-use as well. The big takeaway is that investors need to be ready for strong top-line growth.

    Beyond that, there are other factors investors should understand. First, capital-raising could get challenging. New operations typically consume cash, and not all cannabis companies are in a strong position at this time. Investors need to be in a position to avoid capital raises, as they can now depress the equity price of the issuer substantially.

    A final area that investors should consider is market positioning. There are some multi-state operators that are in many states already and their ability to expand into new states at this time is in question in our view. Simultaneously, there are MSOs that have a more concentrated market presence. The smaller MSOs come to mind, such as Ascend Wellness, Jushi and TerrAscend as well as Planet 13 Holdings. Each of them has new markets coming on now but is also in a position to expand to new markets. The California operators have expansion opportunities as well.

    We remain uncertain about the timing of improved prices for cannabis companies, but, as we said two weeks ago: the current valuations seem too low. We expect prices to rise as the fundamentals stabilize and improve in the future
  • j
    jj
    $VRNOF conversation
    $MSOS, $AYRWF, $CCHWF, $CRLBF, $CURLF, $GTBIF, $JUSHF, $GRWG, $TCNNF, $TRSSF, $VRNOF This week’s commentary by Alan Brochstein
    Friends,
    Alan Brochstein here! Cannabis stocks finally rallied this week slightly. Since we shared our sector bullishness in this newsletter a few weeks ago, the Global Cannabis Stock Index has actually dropped a lot. The index is up nearly 4% from the multi-year closing low set during this week, and, at 16.34, it is down about 15% in June and has fallen by over 50% in 2022. With little chance of recovering the June loss in the next four days, it appears that this will be the 18th consecutive monthly decline. We will soon detail the performance for the month of all seven of our indexes.

    This weekend in a video for subscribers at 420 Investor, I described how a lot of the stocks I follow are testing or have taken out the lows from March of 2020. Since then, the S&P 500 is up about 77%. Simply put, the cannabis sector has been absolutely hammered. We have shared in the past our reasons for being bullish: the expansion of many state markets into adult-use, the addition of new dispensaries in Illinois and very low valuations in our view.

    We always try to understand the sentiment in the cannabis sector. Right now, sentiment is generally negative, which encourages us as contrarians. When we look at the stocks and the sub-sectors, we see a very oversold market. The Global Cannabis Stock Index made a new 52-week closing low this week at 15.76 on Wednesday. For perspective, we think it's important to remember that the closing low in March 2020 was slightly higher than our close Friday (16.42 then, 16.32 now). It's a near double-bottom!

    The American Cannabis Operators Index is down a bit less than the overall market, having declined by nearly 47% in 2022, while the Ancillary Cannabis Index has fallen by more (53.8%). While the overall Canadian market has declined about the same as the overall market, the largest ones have been sold aggressively. Canadian Cannabis LP Tier 1 Index, which consists of five companies doing more than $30 million in quarterly revenue, has declined more than 56% and trades well below the 2020 low now. Aurora Cannabis, Canopy Growth, HEXO Corp. and Organigram have made recent lows below the 2020 lows, while Tilray still holds above its 2020 low.

    When looking at the prices, there are two factors that we like to assess: oversold and overextended. The way we measure oversold is by comparing to the 150-day moving average, and the 29 stocks on the 420 Investor Focus List are anywhere from 13% to 76% below that level currently. The average is 43% below. This is quite oversold in our view. When looking at a chart, we define a trend as overextended when the 10-dma has been below the 50-dma and the 50-dma below the 150-dma for more than 13 weeks. The stocks are for the most part overextended to the downside, with several names reaching that point in mid-July.

    Cannabis stocks being oversold and overextended to the downside sets us up for at least a bounce if the rally we expect doesn't materialize. Cannabis stocks are very out of favor now, and we continue to believe that this is a good time for investors to increase their exposure.
  • j
    jj
    $VRNOF conversation
    $MSOS, $AYRWF, $CCHWF, $CRLBF, $CURLF, $GTBIF, $JUSHF, $GRWG, $TCNNF, $TRSSF, $VRNOF
    The AUM dropped further to $570.3 millions. The Etf MSOS had several changes to the top ten positions this past week. Position changes:
    GTBIF. +50k
    VRNOF +100k
    TRSSF +100k
    GRWG - 5k
  • T
    Tom
    I watch this share price and Cresco's and quickly realize that I am trading with a lot of incompetent folks.
  • S
    STARWOOD
    When is merger taking place.
  • m
    marcus
    So they opened their second grow facility which is 270 k Sq feet , the first is 50 k Sq feet .
    Does anybody know what size their 3 rd facility is ? That is opening by the end of year ?
    Thanks
  • M
    Maverick
    Americans spent more of MJ than Starbucks in 2021. This could be the best trade of the decade right here.
  • D
    Dead Head
    Someone is deleting calls for CS to be investigated for corruption.
  • j
    jj
    $VRNOF conversation
    $MSOS, $AYRWF, $CCHWF, $CRLBF, $CURLF, $GTBIF, $JUSHF, $GRWG, $TCNNF, $TRSSF, $VRNOF
    The AUM dropped further to $517.5 millions. The Etf MSOS had several changes to the top ten positions this past week. Position changes:
    GTBIF +300k, CURLF +100k, GRWG -14k. The top 10 still account for 82.5% of the portfolio.
  • j
    jj
    $VRNOF conversation
    $MSOS, $AYRWF, $CCHWF, $CRLBF, $CURLF, $GTBIF, $JUSHF, $GRWG, $TCNNF, $TRSSF, $VRNOF This week’s commentary by Alan Brochstein
    focused on Canopy Growth. For the full story see NCV which will contain the commentary later today. $CGC
  • j
    jj
    $VRNOF conversation
    $MSOS, $AYRWF, $CCHWF, $CRLBF, $CURLF, $GTBIF, $JUSHF, $GRWG, $TCNNF, $TRSSF, $VRNOF

    The lead story in today’s edition of NCV is about states’ sales figures
    https://www.newcannabisventures.com/cannabis-sales-grow-5-sequentially-to-1-68-billion/
  • m
    mark A
    Need some help here. I see that Cresco is buying Columbia for $ 3.64 US $$ per Columbia share, is that correct.?? I am trying to decide whether to buy Columbia Care in the next 2 days or Cresco. What do the folks here think the best buy is, seems Columbia but What am I missing here, or is Columbia a screaming deal. Ultimately I want to own Cresco once the deal closes end of year. So who is the best to buy now.???